Tg Therapeutics (TGTX) Stock Price, Quote & News

Company Profile

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's de...

Industry: Biotechnology

Sector: Healthcare

Phone: 212 554 4484

Fax: 212 554 4531

Website: www.tgtherapeutics.com

Address:

3020 Carrington Mill Blvd., Suite 475, Morrisville, United States

TheGunnerAB Jan. 7 at 3:01 AM

$TGTX just ask yourself how many BP would love to add $1B to their 2026 revenues via an acquisition? Especially, extremely profitable revenue strram.

1 · Reply

mb0157 Jan. 7 at 1:35 AM

$TGTX this is trading like something’s gonna shake next week. Highly unusual activity. You’ll know Friday afternoon if options market on this one gets nutty

0 · Reply

ngnol Jan. 7 at 12:52 AM

$TGTX have we heard anything from the conference? Didn’t they present after market close?

1 · Reply

spirit1 Jan. 7 at 12:29 AM

$TGTX TG has lived in a valuation penalty box for far too long. The first half of the year should pull TG into being recognized for what they can become. Nail down Permira/NP ex-US rights. Outcome favors TG behalf. Data on SC progress. Not a new drug just a dosage and frequency adjustment. Again, not high risk. Revenue growth tackling one billion this year. Again, based on 2025 growth not high risk. All of the above I don't see as high risk they just need to complete, or TG needs to provide positive progress. Don't own this company for a buyout, but for organic growth. The market has shown it doesn't know how to price it even close to what is coming.

1 · Reply

Sciguy67 Jan. 6 at 10:45 PM

$TGTX love if you feel sp will be above 35 after the conference if not what is your prediction

1 · Reply

ChartistMoM Jan. 6 at 9:48 PM

$TGTX This is my son's other account. Please don't mind him. He's off his meds. Love, mom.

1 · Reply

CT_Biker Jan. 6 at 9:18 PM

$TGTX Sold a few PUTS :-)

0 · Reply

RandandKaren Jan. 6 at 9:07 PM

$TGTX new account made today when hit piece comes out

1 · Reply

RandandKaren Jan. 6 at 9:06 PM

$TGTX this is how you know the shorts are back

1 · Reply

7340OA Jan. 6 at 8:56 PM

$TGTX Might be tempted to pick up more if it gets back to 19 or 20 ... seems plausible at this rate. 🤣

0 · Reply

TG Therapeutics: What Wall Street Isn't Telling You

Nov 28, 2025, 7:30 AM EST - 5 weeks ago

TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference

Nov 18, 2025, 5:23 PM EST - 7 weeks ago

TG Therapeutics: Concerns About Slowing Growth And New Competition

Nov 17, 2025, 5:49 PM EST - 7 weeks ago

TG Therapeutics: Positives From Q3'25 Earnings, But Competitors Progressing

Nov 3, 2025, 3:48 PM EST - 2 months ago

TG Therapeutics Q3 Earnings: Strong Quarter For Briumvi As CD20 Market Grows

Nov 3, 2025, 11:56 AM EST - 2 months ago

TG Therapeutics, Inc. (TGTX) Q3 2025 Earnings Call Transcript

Oct 31, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update

Oct 28, 2025, 7:30 AM EDT - 2 months ago

TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI

Sep 24, 2025, 9:10 AM EDT - 3 months ago

New Data for BRIUMVI® Demonstrate 89.9% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 6 Years of Continuous BRIUMVI Treatment

Sep 10, 2025, 7:30 AM EDT - 4 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

Sep 8, 2025, 7:30 AM EDT - 4 months ago

TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment

Sep 4, 2025, 7:57 AM EDT - 4 months ago

TG Therapeutics, Inc. (TGTX) Presents at Cantor Global Healthcare Conference 2025 Transcript

Sep 4, 2025, 7:30 AM EDT - 4 months ago

TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 3, 2025, 7:30 AM EDT - 4 months ago

TG Therapeutics Announces Completion of Existing Share Repurchase Program and Authorization of New $100 Million Program

Aug 28, 2025, 8:00 AM EDT - 4 months ago

TG Therapeutics to Participate in the Cantor Global Healthcare Conference

Aug 4, 2025, 10:19 AM EDT - 5 months ago

TG Therapeutics, Inc. (TGTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:00 AM EDT - 5 months ago

TG Therapeutics Reports Second Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance

Jul 30, 2025, 7:30 AM EDT - 5 months ago

TG Therapeutics to Host Conference Call on Second Quarter 2025 Financial Results and Business Update

Jun 25, 2025, 4:05 PM EDT - 6 months ago

TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel

Jun 9, 2025, 4:51 PM EDT - 7 months ago

Evercore ISI's Julian Emanuel says now is the time to buy small-caps

CNS LEU RMBS SFM

Jun 6, 2025, 7:30 AM EDT - 7 months ago

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 6:00 AM EDT - 7 months ago

TG Therapeutics: Estimates Could Soon Be Raised Again

May 27, 2025, 7:30 AM EDT - 8 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting

May 5, 2025, 4:37 PM EDT - 8 months ago

TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show

May 5, 2025, 1:30 PM EDT - 8 months ago

TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges

May 5, 2025, 10:55 AM EDT - 8 months ago

TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript

May 5, 2025, 7:00 AM EDT - 8 months ago

TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance

Apr 30, 2025, 7:30 AM EDT - 8 months ago

TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update

Apr 10, 2025, 7:30 AM EDT - 9 months ago

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Apr 7, 2025, 7:30 AM EDT - 9 months ago

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

Mar 21, 2025, 11:50 AM EDT - 10 months ago

Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher

Mar 15, 2025, 8:42 AM EDT - 10 months ago

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel

Mar 14, 2025, 2:04 PM EDT - 10 months ago

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials

Mar 12, 2025, 4:11 PM EDT - 10 months ago

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter

Mar 7, 2025, 7:30 AM EST - 10 months ago

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Mar 4, 2025, 7:03 AM EST - 11 months ago

Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025

CORT GILD PRVA TKO

Mar 3, 2025, 3:59 PM EST - 11 months ago

TG Therapeutics: A Wonderful Hold

Mar 3, 2025, 11:55 AM EST - 11 months ago

TG Therapeutics, Inc. (TGTX) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 7:30 AM EST - 11 months ago

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

Feb 26, 2025, 7:30 AM EST - 11 months ago

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

Feb 18, 2025, 10:20 AM EST - 11 months ago

20 stocks of companies expected to put up numbers to back investors' new ‘growth mindset'

ARWR AUB CRK CYTK EXE KRYS MARA

Jan 23, 2025, 2:48 PM EST - 1 year ago

TG Therapeutics: Entering 2025 With Increased Investor Expectations

Jan 21, 2025, 2:17 AM EST - 1 year ago

TG Therapeutics: 2025 Revenues Will Smash Expectations

Jan 13, 2025, 11:38 PM EST - 1 year ago

TG Therapeutics: Subcutaneous Briumvi Data A Key Near-Term Catalyst

Jan 9, 2025, 7:30 AM EST - 1 year ago

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 4, 2024, 7:36 AM EST - 1 year ago

20 stocks likely to lag the S&P 500 over the next year — for this one reason

CELH CENX CNXC CRSR CXM FLG GEO

Nov 29, 2024, 8:00 AM EST - 1 year ago

TG Therapeutics to Participate in the Evercore HealthCONx Conference

Nov 21, 2024, 6:00 AM EST - 1 year ago

TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Nov 5, 2024, 1:50 PM EST - 1 year ago

TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates

Nov 4, 2024, 8:27 PM EST - 1 year ago

TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here's Why Shares Fell

TheGunnerAB Jan. 7 at 3:01 AM

$TGTX just ask yourself how many BP would love to add $1B to their 2026 revenues via an acquisition? Especially, extremely profitable revenue strram.

1 · Reply

mb0157 Jan. 7 at 1:35 AM

$TGTX this is trading like something’s gonna shake next week. Highly unusual activity. You’ll know Friday afternoon if options market on this one gets nutty

0 · Reply

ngnol Jan. 7 at 12:52 AM

$TGTX have we heard anything from the conference? Didn’t they present after market close?

1 · Reply

spirit1 Jan. 7 at 12:29 AM

1 · Reply

Sciguy67 Jan. 6 at 10:45 PM

$TGTX love if you feel sp will be above 35 after the conference if not what is your prediction

1 · Reply

ChartistMoM Jan. 6 at 9:48 PM

$TGTX This is my son's other account. Please don't mind him. He's off his meds. Love, mom.

1 · Reply

CT_Biker Jan. 6 at 9:18 PM

$TGTX Sold a few PUTS :-)

0 · Reply

RandandKaren Jan. 6 at 9:07 PM

$TGTX new account made today when hit piece comes out

1 · Reply

RandandKaren Jan. 6 at 9:06 PM

$TGTX this is how you know the shorts are back

1 · Reply

7340OA Jan. 6 at 8:56 PM

$TGTX Might be tempted to pick up more if it gets back to 19 or 20 ... seems plausible at this rate. 🤣

0 · Reply

Rutgers Jan. 6 at 8:55 PM

$TGTX just had convo with Shartist, tried to give him benefit of doubt…..thinking TG is going to bankrupt him when it eventually is valued properly!!

0 · Reply

Bankrolls Jan. 6 at 8:52 PM

$TGTX The shartist effect. Start buying when it starts posting. Upwards of 5% gain...it's like the creamer effect. The shartist is trolling right before the JPM conf 😂

0 · Reply

Rutgers Jan. 6 at 8:43 PM

$TGTX That’s a $10MIL they need to come up with if it get’s to $27….youzza…

0 · Reply

TheGunnerAB Jan. 6 at 8:39 PM

$TGTX Someone sold 3760 of May $27 puts for $3.45. It barely moved the stock price.

1 · Reply

7340OA Jan. 6 at 8:27 PM

$TGTX Not sure the big conference coming up is going to do much to lift the SP. Seems hell bent on moving south. Quite unfortunate.

1 · Reply

BobJudes Jan. 6 at 7:26 PM

$TGTX what’s been up here

1 · Reply

biolurker1 Jan. 6 at 7:24 PM

$TGTX I have to thank "Alec". Every time his analysis is published I buy and make 20%-25% in no time.

0 · Reply

BioHedge Jan. 6 at 7:14 PM

$TGTX Chartist is a silly man. He's blocked everyone. That's why he thinks the longs have gone AWOL. He's just a little boy that doesn't like to be challenged. I found out the hard way!

1 · Reply

Chartist0_0 Jan. 6 at 7:13 PM

$TGTX c'mon bulls, don't hide now. If the price was over 50$, you all would be pounding the table, drunk with the idea of enormous profits.

1 · Reply

Luckybreak Jan. 6 at 6:57 PM

$TGTX What the Agree down by over 1.5 million from peak of $ 45 but up by more than that from net purchase price Moron comes in different shapes and form Bullish

0 · Reply

bartuhtuh Jan. 6 at 6:51 PM

$TGTX expected value is a good way to determine if insurance for short term bad news is necessary, especially if your timeline isn’t to hold indefinitely.

0 · Reply

Kobe2324 Jan. 6 at 6:47 PM

$TGTX anyone that still follows chartist, tell that turkey gobbler to go take a glp-1. Nobody has time for his stupidity.

0 · Reply

Market Cap	4.65B
Revenue (ttm)	329.00M
Net Income (ttm)	23.38M
EPS (ttm)	N/A
PE Ratio	10.72
Forward PE	15.33
Profit Margin	7.11%
Debt to Equity Ratio	0.40

Volume	2,856,900
Avg Vol	1,813,814
Day's Range	N/A - N/A
Shares Out	158.76M
Stochastic %K	23%
Beta	1.86
Analysts	Strong Sell
Price Target	$44.28